Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,816 | -246,416 | -185,721 | -123,732 | -59,309 |
| Depreciation Amortization | -87 | -863 | -1,055 | -962 | -823 |
| Accounts payable and accrued liabilities | 2,648 | -992 | 1,526 | 1,000 | 1,604 |
| Other Working Capital | -2,984 | -6,693 | -6,050 | -10,793 | -4,940 |
| Other Operating Activity | 7,822 | 62,733 | 47,077 | 30,385 | 12,471 |
| Operating Cash Flow | $-42,417 | $-192,231 | $-144,223 | $-104,102 | $-50,997 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,484 | -12,381 | -10,933 | -7,850 | -3,937 |
| Purchase Of Investment | -54,789 | -365,039 | -275,475 | -165,691 | -89,274 |
| Sale Of Investment | 65,924 | 445,775 | 369,456 | 237,040 | 163,035 |
| Investing Cash Flow | $8,651 | $68,355 | $83,048 | $63,499 | $69,824 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 191 | 115,068 | 114,666 | 70,027 | 75 |
| Other Financing Activity | -39 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $152 | $115,068 | $114,666 | $70,027 | $75 |
| Beginning Cash Position | 113,112 | 121,920 | 121,920 | 121,920 | 121,920 |
| End Cash Position | 79,498 | 113,112 | 175,411 | 151,344 | 140,822 |
| Net Cash Flow | $-33,614 | $-8,808 | $53,491 | $29,424 | $18,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,417 | -192,231 | -144,223 | -104,102 | -50,997 |
| Capital Expenditure | -2,484 | -12,381 | -10,933 | -7,850 | -3,937 |
| Free Cash Flow | -44,901 | -204,612 | -155,156 | -111,952 | -54,934 |